Collaboration: a big boost for small pharma
It’s an exciting time to be working in the industry; with this comes new opportunities to collaborate and drive innovation
3rd September 2018
Thought Leadership
Race the hurdles of global clinical trials
Inceptua’s Edoardo Madussi shares his insights on how to overcome the challenges of multi-country clinical trials
3rd September 2018
A look at risk-based monitoring, 12 months later
The implementation of risk-based monitoring is moving forward, but it is not without its challenges
3rd September 2018
Napp: leading the way in the biosimilars era
The hard work to support the NHS in adopting biosimilars is not yet complete
3rd September 2018
The rate of lung cancer in young women is now higher than in men
New study reveals lung cancer rates are now higher in young American women than men
29th August 2018
Immune checkpoint inhibitors – why they matter in today's cancer research
Cancer research hinges on developing improved methods to effectively lyse cancer cells. This is where immune checkpoint inhibitors come into direct focus
22nd August 2018
Do we really know our customers?
Why patient centricity throughout the lifecycle is not a fad, sales tactic or trend
17th July 2018
Unlocking potential: How can pharma capitalise on its resources to support the NHS?
Simon Grime, director of Fendix, explains how pharma can utilise its wealth of existing resources and content to improve collaboration with the NHS online
16th July 2018
Tackling pharma’s predatory research problem
Peter Cherry, PhD, Medmeme’s vice president, information systems, explores how pharma can identify predatory journals and conferences
12th July 2018
